EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review

Musa Kiyani, Owen Clanahan, Michael A. Silverman

Journal of Hematology · 2026-10 · 15 (5) · 219-224

DOI: 10.14740/jh2233 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Hematology, 2026-10. Verfasst von Musa Kiyani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kiyani, M., Clanahan, O., & Silverman, M. A. (2026). Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. Journal of Hematology, 15(5), 219-224. https://doi.org/10.14740/jh2233

Vancouver

Kiyani M, Clanahan O, Silverman MA. Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review. Journal of Hematology. 2026;15(5):219-224. doi:10.14740/jh2233

BibTeX
@article{Kiyani2026,
  author = {Kiyani, Musa and Clanahan, Owen and Silverman, Michael A.},
  title = {Heterogeneity in Infection Reporting Across Covalent Bruton Tyrosine Kinase Inhibitor Studies in B-Cell Malignancies: A Systematic Review},
  journal = {Journal of Hematology},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {219--224},
  doi = {10.14740/jh2233}
}
Kostenlos starten →